Sandbox: Verrucous carcinoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(31 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}} {{AE}} {{MV}}
{{CMG}} {{AE}} {{MV}}
   
   
{{SK}}  
{{SK}} Ackerman tumor; Verrucous carcinoma of the skin
   
   
==Overview==
==Overview==


'''Verrucous carcinoma''' (also known as "Snuff dipper's cancer") is rare subtype of [[squamous cell carcinoma]].<ref>Ridge JA, Glisson BS, Lango MN, et al. [http://www.cancernetwork.com/cancer-management-11/chapter04/article/10165/1402663 "Head and Neck Tumors"] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach]. 11 ed. 2008.</ref>  Common causes of verrucous carcinoma, include: [[tobacco]] chewing, or use [[Snuff (tobacco)|snuff]] orally. Patients with oral verrucous carcinoma may be at greater risk of a second oral squamous cell carcinoma. Verrucous carcinoma may occur in various head and neck locations, as well as in the genitalia. The oral cavity is the most common site of this tumor.<ref>Medina JE, Dichtel W, Luna MA. Verrucous-squamous carcinoma of the oral cavity: a clinicopathologic study of 104 cases. Arch Otolaryngol 1984;110:437-40</ref> Verrucous carcinoma is most commonly seen among male patients between 50 to 80 years, and the median age at diagnosis is 67 years.<ref>Tornes K, Bang G, Koppang HS, Pedweson KN. Oral verrucous carcinoma. Int J Oral Surg 1985;14:485-92</ref><ref>Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20</ref> The diagnosic criteria for verrucous carcinoma is  
'''Verrucous carcinoma''' (also known as "Snuff dipper's cancer") is rare subtype of [[squamous cell carcinoma]].<ref>Ridge JA, Glisson BS, Lango MN, et al. [http://www.cancernetwork.com/cancer-management-11/chapter04/article/10165/1402663 "Head and Neck Tumors"] in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) [http://www.cancernetwork.com/cancer-management-11/ Cancer Management: A Multidisciplinary Approach]. 11 ed. 2008.</ref>  Common causes of verrucous carcinoma, include: [[tobacco]] chewing, or use [[Snuff (tobacco)|snuff]] orally. Patients with oral verrucous carcinoma may be at greater risk of a second oral [[Squamous cell carcinoma in situ of skin|squamous cell carcinoma]]. Verrucous carcinoma may occur in various head and neck locations, as well as in the genitalia. The oral cavity is the most common site of this tumor.<ref>Medina JE, Dichtel W, Luna MA. Verrucous-squamous carcinoma of the oral cavity: a clinicopathologic study of 104 cases. Arch Otolaryngol 1984;110:437-40</ref> Verrucous carcinoma is most commonly seen among male patients between 50 to 80 years, and the median age at diagnosis is 67 years.<ref>Tornes K, Bang G, Koppang HS, Pedweson KN. Oral verrucous carcinoma. Int J Oral Surg 1985;14:485-92</ref><ref>Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20</ref> The diagnosic criteria for verrucous carcinoma is biopsy and surgical excision must provide adequate specimens including the full thickness of the tumors and adjacent uninvolved mucosa for correct diagnosis.<ref>McDonald JS, Crissman JD, Gluckman JL. Verrucous Carcinoma of the oral cavity. Head Neck Surg 1982;5:22-8</ref>
Biopsy and surgical excision must provide adequate specimens including the full thickness of the tumors and adjacent uninvolved mucosa for correct diagnosis.<ref>McDonald JS, Crissman JD, Gluckman JL. Verrucous Carcinoma of the oral cavity. Head Neck Surg 1982;5:22-8</ref>


==Historical Perspective==
==Historical Perspective==
*Verrucous carcinoma was first discovered by Lauren V. Ackerman, an American physician in 1948.
*Verrucous carcinoma was first discovered by Lauren V. Ackerman, an American physician in 1948.<ref name="lolol">Lauren Ackerman. Wikipedia.  https://en.wikipedia.org/wiki/Lauren_Ackerman. Accessed on May 11, 2016 </ref>


==Classification==
==Classification==
Line 22: Line 21:


==Pathophysiology==
==Pathophysiology==
*Verrucous carcinoma is characterized as a well-differentiated squamous cell carcinoma with minimal metastatic potential.
*Verrucous carcinoma is characterized as a well-differentiated squamous cell carcinoma with minimal metastatic potential.<ref name="not">Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20</ref>
*The pathogenesis of verrucous carcinoma is not fully understood.  
*The pathogenesis of verrucous carcinoma is not fully understood.<ref name="not">Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20</ref>
*Different locations of verrucous carcinoma, include:
*Different locations of verrucous carcinoma, include:<ref name="not">Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20</ref>
:*Gingiva
 
:*Buccal mucosa
:*[[Gingiva]]
:*[[Buccal mucosa]]
:*Alveolar mucosa
:*Alveolar mucosa
:*Hard palate
:*Hard palate
:*Floor of the mouth
:*Floor of the mouth
:*Larynx
:*[[Larynx]]
:*Esophagus
:*[[Esophagus]]
:*Penis
:*[[Penis]]
:*Vagina
:*[[Vaginal|Vagina]]
:*Scrotum
:*[[Scrotum]]
*There are no genetic mutations associated with the development of verrucous carcinoma.
*There are no genetic mutations associated with the development of verrucous carcinoma.
*On gross pathology, characteristic findings of verrucous carcinoma include:  
*On gross pathology, characteristic findings of verrucous carcinoma include:<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>
:*Cauliflower-like, exophytic mass
:*Cauliflower-like, exophytic mass
*On microscopic histopathological analysis, characteristic findings of verrucous carcinoma include:
*On microscopic histopathological analysis, characteristic findings of verrucous carcinoma include:<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>
:*Exophytic growth
:*Exophytic growth
:*Well-differentiated
:*Well-differentiated
Line 45: Line 45:


==Causes==
==Causes==
* Common causes of verrucous carcinoma, include:
* Common causes of verrucous carcinoma, include:<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>
:*Use snuff orally
:*Use snuff orally
:*Tobacco chewing
:*Tobacco chewing
Line 52: Line 52:


==Differentiating  Verrucous Carcinoma from Other Diseases==
==Differentiating  Verrucous Carcinoma from Other Diseases==
*Verrucous carcinoma must be differentiated from other diseases that cause leukoplakic patches, such as:  
*Verrucous carcinoma must be differentiated from other diseases that cause leukoplakic patches, such as:<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>
:*Keratoacanthoma
:*Keratoacanthoma
:*Giant verruca vulgaris
:*Giant verruca vulgaris
Line 62: Line 62:
===Age===
===Age===
*Verrucous carcinoma is more commonly observed among patients aged 50 to 80 years old.
*Verrucous carcinoma is more commonly observed among patients aged 50 to 80 years old.
*Verrucous carcinoma is more commonly observed among middle-aged and elderly adults.  
*Verrucous carcinoma is more commonly observed among middle-aged and elderly adults.<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>


===Gender===
===Gender===
*Males are more commonly affected with verrucous carcinoma than females.   
*Males are more commonly affected with verrucous carcinoma than females.   
===Race===
===Race===
*There is no racial predilection for verrucous carcinoma.
*Verrucous carcinoma usually affects individuals of the Asian race.<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>


==Risk Factors==
==Risk Factors==
*The most common risk factor in the development of verrucous carcinoma is human papillomavirus (HPV) infection. Other factors, such as schistosomiasis infections, are related to bladder verrucous carcinoma.
*The most common risk factor in the development of verrucous carcinoma is human papillomavirus (HPV) infection. Other factors, such as schistosomiasis infections, are related to bladder verrucous carcinoma.<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>


== Natural History, Complications and Prognosis==
== Natural History, Complications and Prognosis==
*The majority of patients with verrucous carcinoma remain asymptomatic for years.  
*The majority of patients with verrucous carcinoma remain asymptomatic for years.  
*Early clinical features include  
*Early clinical features include translucent patches with erythematous base, and pruritus.
*If left untreated, patients with verrucous carcinoma may progress to develop malignant transformation.  
*If left untreated, patients with verrucous carcinoma may progress to develop malignant transformation.<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>
*Common complications of verrucous carcinoma, include:  
*Common complications of verrucous carcinoma, include:  
:*Metastasis
:*[[Metastasis]]
:*
*Prognosis is generally good, and the 5-survival rate of patients with verrucous carcinoma is approximately 75-80%.<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>
:*
*Prognosis is generally good, and the 5-survival rate of patients with verrucous carcinoma is approximately


== Diagnosis ==
== Diagnosis ==
===Diagnostic Criteria===
*The diagnosis of verrucous carcinoma is made with the following diagnostic criteria:
:*[criterion 1]
:*[criterion 2]
:*[criterion 3]
:*[criterion 4]
=== Symptoms ===
=== Symptoms ===
*Verrucous carcinoma is usually asymptomatic.
*Verrucous carcinoma is usually asymptomatic.
*Symptoms of verrucous carcinoma may include the following:
*Symptoms of verrucous carcinoma may include the following:<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>
:*[symptom 1]
:*Painful lymphadenopathy
:*[symptom 2]
:*Non-healing scar
:*[symptom 3]
:*Pruritus


=== Physical Examination ===
=== Physical Examination ===
*Patients with verrucous carcinoma usually appear malnourished.
*Patients with verrucous carcinoma usually appear malnourished.
*Physical examination may be remarkable for:
*Physical examination may be remarkable for:<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>
:*Slow growing, diffuse, exophytic lesion  
:*Slow growing, diffuse, exophytic lesion  
:*Leukoplakic patches
:*Leukoplakic patches
:*Enlarged regional lymph nodes.
:*Enlarged regional lymph nodes.
:*Painful multiple rugae-like folds and deep clefts.
:*Painful multiple rugae-like folds and deep clefts.
====Gallery====
<gallery>
Image:Verrucous carcinoma01.jpg|Verrucous carcinoma. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
Image:Verrucous carcinoma02.jpg|Verrucous carcinoma. <SMALL><SMALL>''[http://www.atlasdermatologico.com.br/  Adapted from Dermatology Atlas.]''<ref name="Dermatology Atlas">{{Cite web | title = Dermatology Atlas | url = http://www.atlasdermatologico.com.br/}}</ref></SMALL></SMALL>
</gallery>


=== Laboratory Findings ===
=== Laboratory Findings ===
*There are no specific laboratory findings associated with verrucous carcinoma.
*There are no specific laboratory findings associated with verrucous carcinoma.<ref name="pmid7822496">{{cite journal |vauthors=Schwartz RA |title=Verrucous carcinoma of the skin and mucosa |journal=J. Am. Acad. Dermatol. |volume=32 |issue=1 |pages=1–21; quiz 22–4 |year=1995 |pmid=7822496 |doi= |url=}}</ref>


===Imaging Findings===  
===Imaging Findings===  
*[Imaging study 1] is the imaging modality of choice for verrucous carcinoma.
*There are no specific imaging findings for verrucous carcinoma.
*On [imaging study 1], verrucous carcinoma is characterized by [finding 1], [finding 2], and [finding 3].
 
*[Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
== Treatment ==
== Treatment ==
=== Medical Therapy ===
=== Medical Therapy ===
*The mainstay of therapy for verrucous carcinoma, includes:  
*The mainstay of therapy for verrucous carcinoma, may include:<ref name="pmid20396454">{{cite journal |vauthors=Alkan A, Bulut E, Gunhan O, Ozden B |title=Oral verrucous carcinoma: a study of 12 cases |journal=Eur J Dent |volume=4 |issue=2 |pages=202–7 |year=2010 |pmid=20396454 |pmc=2853822 |doi= |url=}}</ref>
:*[[Bleomycin]]
:*[[5-fluorouracil]]
:*[[Cisplatin]]
:*[[Methotrexate]]


=== Surgery ===
=== Surgery ===
*Surgery is the mainstay of therapy for verrucous carcinoma.
*Surgery is the mainstay of therapy for verrucous carcinoma.
*Surgical excision in conjunction with laser therapy  is the most common approach to the treatment of verrucous carcinoma.
*Complete surgical excision (Mohs surgery) is the most common approach to the treatment of verrucous carcinoma.<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>


=== Prevention ===
=== Prevention ===
*Primary preventive measures available for verrucous carcinoma, include:
*Primary preventive measures available for verrucous carcinoma, include:<ref name="pmid7372883">{{cite journal |vauthors=Klima M, Kurtis B, Jordan PH |title=Verrucous carcinoma of skin |journal=J. Cutan. Pathol. |volume=7 |issue=2 |pages=88–98 |year=1980 |pmid=7372883 |doi= |url=}}</ref>
:*Avoid chewing tabacco
:*Avoid chewing tabacco
*Once diagnosed and successfully treated, patients with verrucous carcinoma are followed-up every 3, or 12 months.
*Once diagnosed and successfully treated, patients with verrucous carcinoma are followed-up every 3, or 12 months.

Latest revision as of 15:30, 11 May 2016

WikiDoc Resources for Sandbox: Verrucous carcinoma

Articles

Most recent articles on Sandbox: Verrucous carcinoma

Most cited articles on Sandbox: Verrucous carcinoma

Review articles on Sandbox: Verrucous carcinoma

Articles on Sandbox: Verrucous carcinoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sandbox: Verrucous carcinoma

Images of Sandbox: Verrucous carcinoma

Photos of Sandbox: Verrucous carcinoma

Podcasts & MP3s on Sandbox: Verrucous carcinoma

Videos on Sandbox: Verrucous carcinoma

Evidence Based Medicine

Cochrane Collaboration on Sandbox: Verrucous carcinoma

Bandolier on Sandbox: Verrucous carcinoma

TRIP on Sandbox: Verrucous carcinoma

Clinical Trials

Ongoing Trials on Sandbox: Verrucous carcinoma at Clinical Trials.gov

Trial results on Sandbox: Verrucous carcinoma

Clinical Trials on Sandbox: Verrucous carcinoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sandbox: Verrucous carcinoma

NICE Guidance on Sandbox: Verrucous carcinoma

NHS PRODIGY Guidance

FDA on Sandbox: Verrucous carcinoma

CDC on Sandbox: Verrucous carcinoma

Books

Books on Sandbox: Verrucous carcinoma

News

Sandbox: Verrucous carcinoma in the news

Be alerted to news on Sandbox: Verrucous carcinoma

News trends on Sandbox: Verrucous carcinoma

Commentary

Blogs on Sandbox: Verrucous carcinoma

Definitions

Definitions of Sandbox: Verrucous carcinoma

Patient Resources / Community

Patient resources on Sandbox: Verrucous carcinoma

Discussion groups on Sandbox: Verrucous carcinoma

Patient Handouts on Sandbox: Verrucous carcinoma

Directions to Hospitals Treating Sandbox: Verrucous carcinoma

Risk calculators and risk factors for Sandbox: Verrucous carcinoma

Healthcare Provider Resources

Symptoms of Sandbox: Verrucous carcinoma

Causes & Risk Factors for Sandbox: Verrucous carcinoma

Diagnostic studies for Sandbox: Verrucous carcinoma

Treatment of Sandbox: Verrucous carcinoma

Continuing Medical Education (CME)

CME Programs on Sandbox: Verrucous carcinoma

International

Sandbox: Verrucous carcinoma en Espanol

Sandbox: Verrucous carcinoma en Francais

Business

Sandbox: Verrucous carcinoma in the Marketplace

Patents on Sandbox: Verrucous carcinoma

Experimental / Informatics

List of terms related to Sandbox: Verrucous carcinoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Ackerman tumor; Verrucous carcinoma of the skin

Overview

Verrucous carcinoma (also known as "Snuff dipper's cancer") is rare subtype of squamous cell carcinoma.[1] Common causes of verrucous carcinoma, include: tobacco chewing, or use snuff orally. Patients with oral verrucous carcinoma may be at greater risk of a second oral squamous cell carcinoma. Verrucous carcinoma may occur in various head and neck locations, as well as in the genitalia. The oral cavity is the most common site of this tumor.[2] Verrucous carcinoma is most commonly seen among male patients between 50 to 80 years, and the median age at diagnosis is 67 years.[3][4] The diagnosic criteria for verrucous carcinoma is biopsy and surgical excision must provide adequate specimens including the full thickness of the tumors and adjacent uninvolved mucosa for correct diagnosis.[5]

Historical Perspective

  • Verrucous carcinoma was first discovered by Lauren V. Ackerman, an American physician in 1948.[6]

Classification

  • Verrucous carcinoma may be classified into 5 subtypes:
  • Epithelioma cuniculatum (Ackerman tumor, carcinoma cuniculatum)
  • Buschke–Löwenstein tumor (giant condyloma)
  • Oral florid papillomatosis
  • Subungual keratoacanthoma
  • Gottron's carcinoid papillomatosis

Pathophysiology

  • Verrucous carcinoma is characterized as a well-differentiated squamous cell carcinoma with minimal metastatic potential.[7]
  • The pathogenesis of verrucous carcinoma is not fully understood.[7]
  • Different locations of verrucous carcinoma, include:[7]
  • There are no genetic mutations associated with the development of verrucous carcinoma.
  • On gross pathology, characteristic findings of verrucous carcinoma include:[8]
  • Cauliflower-like, exophytic mass
  • On microscopic histopathological analysis, characteristic findings of verrucous carcinoma include:[8]
  • Exophytic growth
  • Well-differentiated
  • "Glassy" appearance
  • Pushing border - described "elephant feet"

Causes

  • Common causes of verrucous carcinoma, include:[9]
  • Use snuff orally
  • Tobacco chewing
  • Chewing betel nuts (Taiwan)
  • Alcohol consumption

Differentiating Verrucous Carcinoma from Other Diseases

  • Verrucous carcinoma must be differentiated from other diseases that cause leukoplakic patches, such as:[9]
  • Keratoacanthoma
  • Giant verruca vulgaris
  • Nongenital warts
  • Pyoderma vegetans

Epidemiology and Demographics

  • Verrucous carcinoma is very uncommon

Age

  • Verrucous carcinoma is more commonly observed among patients aged 50 to 80 years old.
  • Verrucous carcinoma is more commonly observed among middle-aged and elderly adults.[8]

Gender

  • Males are more commonly affected with verrucous carcinoma than females.

Race

  • Verrucous carcinoma usually affects individuals of the Asian race.[8]

Risk Factors

  • The most common risk factor in the development of verrucous carcinoma is human papillomavirus (HPV) infection. Other factors, such as schistosomiasis infections, are related to bladder verrucous carcinoma.[9]

Natural History, Complications and Prognosis

  • The majority of patients with verrucous carcinoma remain asymptomatic for years.
  • Early clinical features include translucent patches with erythematous base, and pruritus.
  • If left untreated, patients with verrucous carcinoma may progress to develop malignant transformation.[9]
  • Common complications of verrucous carcinoma, include:
  • Prognosis is generally good, and the 5-survival rate of patients with verrucous carcinoma is approximately 75-80%.[9]

Diagnosis

Symptoms

  • Verrucous carcinoma is usually asymptomatic.
  • Symptoms of verrucous carcinoma may include the following:[8]
  • Painful lymphadenopathy
  • Non-healing scar
  • Pruritus

Physical Examination

  • Patients with verrucous carcinoma usually appear malnourished.
  • Physical examination may be remarkable for:[8]
  • Slow growing, diffuse, exophytic lesion
  • Leukoplakic patches
  • Enlarged regional lymph nodes.
  • Painful multiple rugae-like folds and deep clefts.

Gallery

Laboratory Findings

  • There are no specific laboratory findings associated with verrucous carcinoma.[9]

Imaging Findings

  • There are no specific imaging findings for verrucous carcinoma.

Treatment

Medical Therapy

  • The mainstay of therapy for verrucous carcinoma, may include:[11]

Surgery

  • Surgery is the mainstay of therapy for verrucous carcinoma.
  • Complete surgical excision (Mohs surgery) is the most common approach to the treatment of verrucous carcinoma.[8]

Prevention

  • Primary preventive measures available for verrucous carcinoma, include:[8]
  • Avoid chewing tabacco
  • Once diagnosed and successfully treated, patients with verrucous carcinoma are followed-up every 3, or 12 months.
  • Follow-up testing, include: regular skin examinations.

References

  1. Ridge JA, Glisson BS, Lango MN, et al. "Head and Neck Tumors" in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach. 11 ed. 2008.
  2. Medina JE, Dichtel W, Luna MA. Verrucous-squamous carcinoma of the oral cavity: a clinicopathologic study of 104 cases. Arch Otolaryngol 1984;110:437-40
  3. Tornes K, Bang G, Koppang HS, Pedweson KN. Oral verrucous carcinoma. Int J Oral Surg 1985;14:485-92
  4. Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20
  5. McDonald JS, Crissman JD, Gluckman JL. Verrucous Carcinoma of the oral cavity. Head Neck Surg 1982;5:22-8
  6. Lauren Ackerman. Wikipedia. https://en.wikipedia.org/wiki/Lauren_Ackerman. Accessed on May 11, 2016
  7. 7.0 7.1 7.2 Koch BB, Trask DK, Hoffman HT, Karnell LH, Robinson RA, Zhen W, Menck HR. National survey of head and neck verrucous carcinoma. Cancer 2001;92:110-20
  8. 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 Klima M, Kurtis B, Jordan PH (1980). "Verrucous carcinoma of skin". J. Cutan. Pathol. 7 (2): 88–98. PMID 7372883.
  9. 9.0 9.1 9.2 9.3 9.4 9.5 Schwartz RA (1995). "Verrucous carcinoma of the skin and mucosa". J. Am. Acad. Dermatol. 32 (1): 1–21, quiz 22–4. PMID 7822496.
  10. 10.0 10.1 "Dermatology Atlas".
  11. Alkan A, Bulut E, Gunhan O, Ozden B (2010). "Oral verrucous carcinoma: a study of 12 cases". Eur J Dent. 4 (2): 202–7. PMC 2853822. PMID 20396454.